DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Yu ML, Hung CH, Cheng PN. et al.
Efficacy of 8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-Naive Chronic Hepatitis C Genotype 1b Patients with Mild Fibrosis: An Open-Label, Randomized, Active Control Trial (EGALITE)-Interim Report.

Hepatology 2018;
68: 595a-596a

Download Bibliographical Data

Search in: